当前位置:首页 - 行情中心 - 川宁生物(301301) - 财务分析

川宁生物

(301301)

  

流通市值:71.01亿  总市值:256.79亿
流通股本:6.16亿   总股本:22.27亿

川宁生物(301301)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润2.88亿元,每股收益0.13元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益820719.71万元,未分配利润234915.12万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产1073254.33万元,负债252534.62万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入1,296,949,550.165,758,307,742.654,456,265,553.383,195,426,670.39
营业总成本947,594,552.574,059,755,762.33,154,494,351.32,264,062,909.63
营业利润353,331,784.321,687,762,925.681,294,715,549.77919,680,528.83
利润总额350,002,745.911,675,091,839.311,277,922,127.14909,157,129.09
净利润288,206,596.521,400,350,219.971,075,957,079.13766,327,623.76
其他综合收益--99,338.34--
综合收益总额288,206,596.521,400,250,881.631,075,957,079.13766,327,623.76
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计4,416,378,924.564,144,223,873.544,088,077,855.644,080,156,983.02
非流动资产合计6,316,164,332.276,409,356,087.636,463,298,638.296,519,008,097.56
资产总计10,732,543,256.8310,553,579,961.1710,551,376,493.9310,599,165,080.58
流动负债合计1,972,067,762.091,947,534,889.661,996,994,497.662,122,261,813.74
非流动负债合计553,278,437.67689,629,227.58965,170,787.41,206,163,345.86
负债合计2,525,346,199.762,637,164,117.242,962,165,285.063,328,425,159.6
归属于母公司股东权益合计8,188,380,183.447,897,587,034.117,570,369,941.777,257,844,675.93
股东权益合计8,207,197,057.077,916,415,843.937,589,211,208.877,270,739,920.98
负债和股东权益合计10,732,543,256.8310,553,579,961.1710,551,376,493.9310,599,165,080.58
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计648,163,490.344,783,112,022.393,165,660,715.722,211,561,298.13
经营活动现金流出小计531,578,949.822,992,044,746.042,290,401,046.281,439,134,827.5
经营活动产生的现金流量净额116,584,540.521,791,067,276.35875,259,669.44772,426,470.63
投资活动现金流入小计200,464,358.91206,184,133.59201,145,426.03246,200
投资活动现金流出小计422,965,903.29312,401,377.78312,628,060.1370,411,589.81
投资活动产生的现金流量净额-222,501,544.38-106,217,244.19-111,482,634.1-70,165,389.81
筹资活动现金流入小计0806,191,920716,191,920340,260,920
筹资活动现金流出小计28,751,355.042,167,261,088.141,620,322,311.82886,771,986.03
筹资活动产生的现金流量净额-28,751,355.04-1,361,069,168.14-904,130,391.82-546,511,066.03
汇率变动对现金及现金等价物的影响1,905,343.16,537,247.241,255,140.022,995,954.97
现金及现金等价物净增加额-132,763,015.8330,318,111.26-139,098,216.46158,745,969.76
期末现金及现金等价物余额952,641,363.261,088,331,674.61618,915,346.89916,759,533.11
最新报告期:2025-04-30
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
民生证券杨涛,王班0.630.630.652025-04-30
中信建投刘若飞,王云鹏,袁清慧,贺菊颖,赖俊勇0.640.690.752025-04-25
中信证券李超,陈竹,韩世通0.760.850.932025-04-23
TOP↑